Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer
Conditions:   Prostate Cancer;   Chemotherapy Effect;   Hormone Sensitive Prostate Cancer;   Locally Advanced Prostate Carcinoma Interventions:   Drug: Neoadjuvant chemotherapy combined with hormone therapy;   Drug: Neoadjuvant hormone therapy;   Procedure: Radical Prostatectomy (RP)+ extended lymph node dissection Sponsor:   RenJi Hospital Not yet recruiting (Source:
Source: - January 7, 2020 Category: Research Source Type: clinical trials

ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
Condition:   Metastatic Breast Cancer Intervention:   Drug: Hormonal therapy-based treatments Sponsors:   National Taiwan University Hospital;   Novartis Recruiting (Source:
Source: - December 27, 2019 Category: Research Source Type: clinical trials

Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
Condition:   Metastatic Castration-resistent Prostate Cancer Interventions:   Drug: Docetaxel;   Drug: Abiraterone Acetate or Enzalutamide Sponsor:   National Cancer Institute, Naples Recruiting (Source:
Source: - October 25, 2019 Category: Research Source Type: clinical trials

Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer
Conditions:   Positive Lymph Node;   Prostate Adenocarcinoma;   PSA Level Greater Than Zero;   Stage I Prostate Cancer AJCC v8;   Stage II Prostate Cancer AJCC v8;   Stage IIA Prostate Cancer AJCC v8;   Stage IIB Prostate Cancer AJCC v8;   Stage IIC Prostate Cancer AJCC  v8;   Stage III Prostate Cancer AJCC v8;   Stage IIIA Prostate Cancer AJCC v8;   Stage I...
Source: - October 22, 2019 Category: Research Source Type: clinical trials